MultiplAI leverages genomics and AI to provide universal remote screening for cardiovascular diseases among other complex diseases. We use a liquid biopsy of whole blood based on RNA sequencing and deep learning looking at all biomarkers in the blood, thus creating a superbiomarker to detect diseases earlier. Our test can be used in continuous testing both for preventative screening and post-treatment monitoring. Given that it requires only a simple blood sample, it can be administered remotely, anywhere, and costs a fraction of existing diagnostic methods.
Location: United Kingdom, England, London
Employees: 11-50
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | First In V... | firstinven... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 04.11.2021 | 10 new data-driven health companies selected for KQ Labs acc... | 10 innovative start-up companies working at the interface of biomedical and data science are to rece... | lifearc.or... |
| 12.02.2021 | StartUPDATES: New developments from healthcare startups | Turing, based in Palo Alto, California, announced its second virtual remote work conference, Turing ... | medcitynew... |
| - | StartUPDATES: New developments from healthcare startups | Turing, based in Palo Alto, California, announced its second virtual remote work conference, Turing ... | medcitynew... |